Relapsed/Refractory PTCLT With at Least One Line of Prior Systemic Therapy
1 clinical trials · Condition
◉ Watch Relapsed/Refractory PTCLT With at Least One Line of Prior Systemic Therapy
| Record | Firm | Date |
|---|---|---|
| SHR2554 Clinical Study of Chidamide in the Treatment of T-cell Lymphoma (NCT06122389) | Jiangsu HengRui Medicine Co., Ltd. | 2024-02-05 |
Track Relapsed/Refractory PTCLT With at Least One Line of Prior Systemic Therapy automatically
Every clearance here is in the API, with alerts when new ones post.